Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$2.91 - $3.83 $211,266 - $278,058
-72,600 Closed
0 $0
Q3 2020

Nov 05, 2020

BUY
$3.69 - $7.09 $37,638 - $72,318
10,200 Added 16.35%
72,600 $283,000
Q2 2020

Aug 12, 2020

BUY
$3.58 - $7.44 $66,040 - $137,245
18,447 Added 41.97%
62,400 $464,000
Q4 2019

Jan 27, 2020

BUY
$6.27 - $11.41 $275,585 - $501,503
43,953 New
43,953 $405,000

Others Institutions Holding OPTN

About OptiNose, Inc.


  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $483M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.